RAPA, IDA
RAPA, IDA
ONCOLOGIA
[Immunohistochemistry in thyroid needle aspiration samples]
2005-01-01 PAPOTTI M; FORNARI A; RAPA I; CAPPIA S; BERGERO N; SAGGIORATO E; VOLANTE M
Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.
2007-01-01 SAGGIORATO E; RAPA I; GARINO F; BUSSOLATI G; ORLANDI F; PAPOTTI M; VOLANTE M
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases
2013-01-01 La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
2019-01-01 Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo
Androgen deprivation modulates gene expression profile along prostate cancer progression
2016-01-01 Volante, Marco; Tota, Daniele; Giorcelli, Jessica; Bollito, Enrico; Napoli, Francesca; Vatrano, Simona; Buttigliero, Consuelo; Molinaro, Luca; Gontero, Paolo; Porpiglia, Francesco; Tucci, Marcello; Papotti, Mauro; Berruti, Alfredo; Rapa, Ida
Biological role and clinical significance of CD157 in epithelial ovarian cancer
2011-01-01 Nicola, Lo Buono; Rossella, Parrotta; Riccardo, Arisio; Dyonissios, Katsaros; Ida, Rapa; Enza, Ferrero; Marco, Volante; Erika, Ortolan; Ada, Funaro
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer
2013-01-01 S. Morone; N. Lo Buono; A. Giacomino; R. Parrotta; R. Arisio; D. Katsaros; N. Biglia; G. Chiorino; I. Rapa; M. Volante; E. Ortolan; A. Funaro
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth
2006-01-01 I. RAPA; M. VOLANTE; S. CAPPIA; R. ROSAS; GV. SCAGLIOTTI; M. PAPOTTI
CD157 as a potential pleural effusion biomarker for malignant mesothelioma
2017-01-01 Simona, Morone; Stefania, Capano; Alice, Giacomino; Stefania, Augeri; Erika, Ortolan; Ida, Rapa; Luisella Righi and Ada Funaro,
CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME
2009-01-01 P. Bovino; E. Ortolan; S. Morone; N. Lo-Buono; R. Parrotta; M. El-Baroudi; I. Rapa; M. Volante; E. Ferrero; D. Katsaros; R. Arisio; F. Malavasi; A. Funaro
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
2014-01-01 Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness
2012-01-01 A. Giacomino; S. Morone; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; E. Ortolan; A. Funaro
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study
2014-01-01 Lanzo G; Borghese G; Arisio R; Katsaros D; Volante M; Rapa I; Benedetto C; Ortolan E; Funaro A.
CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER
2014-01-01 G. Borghese; G. Lanzo; R. Benvenuto; R. Arisio; D. Katsaros; M. Volante; I. Rapa; E. Ortolan; C. Benedetto; A. Funaro
Clinical and biological significance of CD157 in malignant pleural mesothelioma
2011-01-01 S. Morone; E. Ortolan; A. Giacomino; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; S. Demichelis; G. Rovere; S. Novello; F. Malavasi; A. Funaro.
Clinical and biological significance of CD157 in ovarian carcinoma
2011-01-01 E. Ortolan; N. Lo Buono; S. Morone; R. Parrotta; R. Arisio; D. Katsaros; I. Rapa; E. Ferrero; M. Volante; A. Funaro
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
2018-01-01 Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo*
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.
2014-01-01 Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M.
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas
2018-01-01 Vatrano, Simona; Volante, Marco*; Duregon, Eleonora; Giorcelli, Jessica; Izzo, Stefania; Rapa, Ida; Votta, Arianna; Germano, Antonina; Scagliotti, Giorgio; Berruti, Alfredo; Terzolo, Massimo; Papotti, Mauro
Differential expression profiles of cell-to-matrix-related molecules in adrenal cortical tumors: Diagnostic and prognostic implications
2021-01-01 Volante M.; Rapa I.; Metovic J.; Napoli F.; Tampieri C.; Duregon E.; Terzolo M.; Papotti M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Immunohistochemistry in thyroid needle aspiration samples] | 2005 | PAPOTTI M; FORNARI A; RAPA I; CAPPIA S; BERGERO N; SAGGIORATO E; VOLANTE M | |
| Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. | 2007 | SAGGIORATO E; RAPA I; GARINO F; BUSSOLATI G; ORLANDI F; PAPOTTI M; VOLANTE M | |
| Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases | 2013 | La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C | |
| Activity and safety of temozolomide in advanced adrenocortical carcinoma patients | 2019 | Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo | |
| Androgen deprivation modulates gene expression profile along prostate cancer progression | 2016 | Volante, Marco; Tota, Daniele; Giorcelli, Jessica; Bollito, Enrico; Napoli, Francesca; Vatrano, Simona; Buttigliero, Consuelo; Molinaro, Luca; Gontero, Paolo; Porpiglia, Francesco; Tucci, Marcello; Papotti, Mauro; Berruti, Alfredo; Rapa, Ida | |
| Biological role and clinical significance of CD157 in epithelial ovarian cancer | 2011 | Nicola, Lo Buono; Rossella, Parrotta; Riccardo, Arisio; Dyonissios, Katsaros; Ida, Rapa; Enza, Ferrero; Marco, Volante; Erika, Ortolan; Ada, Funaro | |
| Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer | 2013 | S. Morone; N. Lo Buono; A. Giacomino; R. Parrotta; R. Arisio; D. Katsaros; N. Biglia; G. Chiorino; I. Rapa; M. Volante; E. Ortolan; A. Funaro | |
| Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth | 2006 | I. RAPA; M. VOLANTE; S. CAPPIA; R. ROSAS; GV. SCAGLIOTTI; M. PAPOTTI | |
| CD157 as a potential pleural effusion biomarker for malignant mesothelioma | 2017 | Simona, Morone; Stefania, Capano; Alice, Giacomino; Stefania, Augeri; Erika, Ortolan; Ida, Rapa; Luisella Righi and Ada Funaro, | |
| CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME | 2009 | P. Bovino; E. Ortolan; S. Morone; N. Lo-Buono; R. Parrotta; M. El-Baroudi; I. Rapa; M. Volante; E. Ferrero; D. Katsaros; R. Arisio; F. Malavasi; A. Funaro | |
| CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. | 2014 | Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A | |
| CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness | 2012 | A. Giacomino; S. Morone; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; E. Ortolan; A. Funaro | |
| CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study | 2014 | Lanzo G; Borghese G; Arisio R; Katsaros D; Volante M; Rapa I; Benedetto C; Ortolan E; Funaro A. | |
| CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER | 2014 | G. Borghese; G. Lanzo; R. Benvenuto; R. Arisio; D. Katsaros; M. Volante; I. Rapa; E. Ortolan; C. Benedetto; A. Funaro | |
| Clinical and biological significance of CD157 in malignant pleural mesothelioma | 2011 | S. Morone; E. Ortolan; A. Giacomino; R. Parrotta; N. Lo Buono; I. Rapa; L. Righi; M. Volante; E. Ruffini; S. Demichelis; G. Rovere; S. Novello; F. Malavasi; A. Funaro. | |
| Clinical and biological significance of CD157 in ovarian carcinoma | 2011 | E. Ortolan; N. Lo Buono; S. Morone; R. Parrotta; R. Arisio; D. Katsaros; I. Rapa; E. Ferrero; M. Volante; A. Funaro | |
| CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells | 2018 | Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo* | |
| Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. | 2014 | Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M. | |
| Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas | 2018 | Vatrano, Simona; Volante, Marco*; Duregon, Eleonora; Giorcelli, Jessica; Izzo, Stefania; Rapa, Ida; Votta, Arianna; Germano, Antonina; Scagliotti, Giorgio; Berruti, Alfredo; Terzolo, Massimo; Papotti, Mauro | |
| Differential expression profiles of cell-to-matrix-related molecules in adrenal cortical tumors: Diagnostic and prognostic implications | 2021 | Volante M.; Rapa I.; Metovic J.; Napoli F.; Tampieri C.; Duregon E.; Terzolo M.; Papotti M. |